Rectal spacer use and overall long-term healthcare costs: payer perspective

Rectal spacer use and overall long-term healthcare costs: payer perspective

IntroductionRectal spacers (RS), when used in prostate cancer (PCa) patients treated with radiotherapy (RT), reduce radiation dose to the rectum. While RS incur additional upfront cost, they may result in long-term cost-savings by reducing toxicity-related adverse events and associated medical costs...

Full description

Saved in:
Bibliographic Details
Main Authors: James B. Yu, Ryoko Sato, Michael R. Folkert, Samir Bhattacharyya, Emmanuel Ezekekwu, Daniel A. Hamstra
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
radiotherapy
rectal spacers
healthcare cost
healthcare utilization
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1654925/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2025.1654925/full

Similar Items